{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:12:22Z","timestamp":1794535942433,"version":"4.9.1"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Parathyroid carcinoma (PC) is an extremely rare malignancy, accounting less than 1% of all parathyroid neoplasms, and an uncommon cause of primary hyperparathyroidism (PHPT), characterized by an excessive secretion of parathyroid hormone (PTH) and severe hypercalcemia. As opposed to parathyroid hyperplasia and adenomas, PC is associated with a poor prognosis, due to a commonly unmanageable hypercalcemia, which accounts for death in the majority of cases, and an overall survival rate of 78-85% and 49-70% at 5 and 10 years after diagnosis, respectively. No definitively effective therapies for PC are currently available. The mainly employed treatment for PC is the surgical removal of tumoral gland(s). Post-surgical persistent or recurrent disease manifest in about 50% of patients. The comprehension of genetic and epigenetic bases and molecular pathways that characterize parathyroid carcinogenesis is important to distinguish malignant PCs from benign adenomas, and to identify specific targets for novel therapies. Germline heterozygote inactivating mutations of the\n                    <jats:italic>CDC73<\/jats:italic>\n                    tumor suppressor gene, with somatic loss of heterozygosity at 1q31.2 locus, account for about 50-75% of familial cases; over 75% of sporadic PCs harbor biallelic somatic inactivation\/loss of\n                    <jats:italic>CDC73<\/jats:italic>\n                    . Recurrent mutations of the\n                    <jats:italic>PRUNE2<\/jats:italic>\n                    gene, a recurrent mutation in the\n                    <jats:italic>ADCK1<\/jats:italic>\n                    gene, genetic amplification of the\n                    <jats:italic>CCND1<\/jats:italic>\n                    gene, alterations of the PI3K\/AKT\/mTOR signaling pathway, and modifications of microRNA expression profile and gene promoter methylation pattern have all been detected in PC. Here, we review the current knowledge on gene mutations and epigenetic changes that have been associated with the development of PC, in both familial and sporadic forms of this malignancy.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2022.834362","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T07:58:17Z","timestamp":1645689497000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Genetics and Epigenetics of Parathyroid Carcinoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Francesca","family":"Marini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Palmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Perigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0135","article-title":"Atypical Parathyroid Adenomas: Challenging Lesions in the Differential Diagnosis of Endocrine Tumors","volume":"26","author":"Cetani","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"IJE06","DOI":"10.2217\/ije-2017-0011","article-title":"Current and Future Treatments for Parathyroid Carcinoma","volume":"5","author":"Long","year":"2018","journal-title":"Int J Endo Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1200\/JOP.19.00540","article-title":"Contemporary Evaluation and Management of Parathyroid Carcinoma","volume":"17","author":"Fingeret","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7076","article-title":"Clinical Characteristics and Treatment Outcomes of Parathyroid Carcinoma: A Retrospective Review of 234 Cases","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23337","article-title":"Molecular Genetics of Syndromic and Non-Syndromic Forms of Parathyroid Carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mut"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000345675","article-title":"Genetic Defects Associated With Familial and Sporadic Hyperparathyroidism","volume":"41","author":"Hendy","year":"2013","journal-title":"Front Horm Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/275802","article-title":"Molecular Alterations in Sporadic Primary Hyperparathyroidism","volume":"2011","author":"Alvelos","year":"2011","journal-title":"Genet Res Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92061","article-title":"Genomic Profiling Reveals Mutational Landscape in Parathyroid Carcinomas","volume":"2","author":"Pandya","year":"2017","journal-title":"JCI Insight"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0497","article-title":"The Histone Methyltransferase EZH2, an Oncogene Common to Benign and Malignant Parathyroid Tumors","volume":"21","author":"Svedlund","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3238","article-title":"Whole-Exome Sequencing Studies of Parathyroid Carcinomas Reveal Novel PRUNE2 Mutations, Distinctive Mutational Spectra Related to APOBEC-Catalyzed DNA Mutagenesis and Mutational Enrichment in Kinases Associated With Cell Migration and Invasion","volume":"100","author":"Yu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/path.4203","article-title":"Complete Genomic Landscape of a Recurring Sporadic Parathyroid Carcinoma","volume":"230","author":"Kasaian","year":"2013","journal-title":"J Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/PAS.0000000000001017","article-title":"Parafibromin-Deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features","volume":"43","author":"Gill","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-013-0551-9","article-title":"Genetic Basis of Familial Isolated Hyperparathyroidism: A Case Series and a Narrative Review of the Literature","volume":"32","author":"Pontikides","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/000348940711601210","article-title":"Aberrant Methylation of the HRPT2 Gene in Parathyroid Carcinoma","volume":"116","author":"Hewitt","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.12.5052-5060.2005","article-title":"The HRPT2 Tumor Suppressor Gene Product Parafibromin Associates With Human PAF1 and RNA Polymerase II","volume":"25","author":"Yart","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.2.612-620.2005","article-title":"The Parafibromin Tumor Suppressor Protein Is Part of a Human Paf1 Complex","volume":"25","author":"Rozenblatt-Rosen","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2063","article-title":"Gene Expression of Parathyroid Tumors: Molecular Subclassification and Identification of the Potential Malignant Phenotype","volume":"64","author":"Haven","year":"2004","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/srep16714","article-title":"Linker Histone H1.2 Establishes Chromatin Compact and Gene Silencing Through Recognition of H3k27me3","volume":"5","author":"Kim","year":"2015","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp991","article-title":"The Tumor Suppressor, Parafibromin, Mediates Histone H3 K9 Methylation for Cyclin D1 Repression","volume":"38","author":"Yang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300270200","article-title":"The Rtf1 Component of the Paf1 Transcriptional Elongation Complex Is Required for Ubiquitination of Histone H2B","volume":"278","author":"Ng","year":"2003","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.01.053","article-title":"Parafibromin\/Hyrax Activates Wnt\/Wg Target Gene Transcription by Direct Association With Beta-Catenin\/Armadillo","volume":"125","author":"Mosimann","year":"2006","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-06-0129","article-title":"Nuclear Localization of the Parafibromin Tumor Suppressor Protein Implicated in the Hyperparathyroidism-Jaw Tumor Syndrome Enhances Its Proapoptotic Function","volume":"5","author":"Lin","year":"2007","journal-title":"Mol Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0272","article-title":"Defective Nucleolar Localization and Dominant Interfering Properties of a Parafibromin L95P Missense Mutant Causing the Hyperparathyroidism-Jaw Tumor Syndrome","volume":"17","author":"Panicker","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of Parafibromin Immunoreactivity Is a Distinguishing Feature of Parathyroid Carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10523","article-title":"Primary Hyperparathyroidism Caused by Parathyroid-Targeted Overexpression of Cyclin D1 in Transgenic Mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/me.2005-0116","article-title":"Abnormal Parathyroid Cell Proliferation Precedes Biochemical Abnormalities in a Mouse Model of Primary Hyperparathyroidism","volume":"19","author":"Mallya","year":"2005","journal-title":"Mol Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114114","article-title":"Molecular Cloning and Chromosomal Mapping of DNA Rearranged With the Parathyroid Hormone Gene in a Parathyroid Adenoma","volume":"83","author":"Arnold","year":"1989","journal-title":"J Clin Invest"},{"key":"B28","article-title":"Overexpression of Cyclin D1 Contributes to Malignancy by Up-Regulation of Fibroblast Growth Factor Receptor 1 via the pRB\/E2F Pathway","volume":"63","author":"Tashiro","year":"2003","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0892-y","article-title":"EZH2 and ZFX Oncogenes in Malignant Behaviour of Parathyroid Neoplasms","volume":"54","author":"Sanpaolo","year":"2016","journal-title":"Endocrine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of Somatic Mutations in Parathyroid Tumors Using Whole-Exome Sequencing","volume":"97","author":"Cromer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00246","article-title":"Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas","volume":"159","author":"Wei","year":"2018","journal-title":"Endocrinology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3136","article-title":"Hypermethylated in Cancer 1 (HIC1), a Tumor Suppressor Gene Epigenetically Deregulated in Hyperparathyroid Tumors by Histone H3 Lysine Modification","volume":"97","author":"Svedlund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3390\/cancers13163949","article-title":"The Pathogenic Role of PI3K\/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review","volume":"13","author":"Rascio","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.3390\/ijms22042016","article-title":"Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid Tumors","volume":"22","author":"Tavanti","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0668","article-title":"Filamin A and Parafibromin Expression in Parathyroid Carcinoma","volume":"185","author":"Storvall","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1530\/JME-16-0184","article-title":"Filamin A Is Reduced and Contributes to the CASR Sensitivity in Human Parathyroid Tumors","volume":"58","author":"Mingione","year":"2017","journal-title":"J Mol Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2017.88","article-title":"Expression, Function, and Regulation of the Embryonic Transcription Factor TBX1 in Parathyroid Tumors","volume":"97","author":"Verdelli","year":"2017","journal-title":"Lab Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009472","article-title":"Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours","volume":"5","author":"Juhlin","year":"2010","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"646e655","DOI":"10.4161\/epi.24823","article-title":"Global and Gene-Specific Promoter Methylation Analysis in Primary Hyperparathyroidism","volume":"8","author":"Sulaiman","year":"2013","journal-title":"Epigenetics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20895","article-title":"The DNA Methylome of Benign and Malignant Parathyroid Tumors","volume":"50","author":"Starker","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1476-4598-9-294","article-title":"Aberrant WNT\/beta-Catenin Signaling in Parathyroid Carcinoma","volume":"9","author":"Svedlund","year":"2010","journal-title":"Mol Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/s0039-6060(03)00422-7","article-title":"Intragenic Allelic Loss and Promoter Hypermethylation of the RIZ1 Tumor Suppressor Gene in Parathyroid Tumors and Pheochromocytomas","volume":"134","author":"Carling","year":"2003","journal-title":"Surgery"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab626","article-title":"Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis","volume":"107","author":"Singh","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1359-7","article-title":"Identification of Differentially Expressed microRNA in Parathyroid Tumors","volume":"18","author":"Rahbari","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0134","article-title":"Differential Expression of microRNAs in Human Parathyroid Carcinomas Compared With Normal Parathyroid Tissue","volume":"17","author":"Corbetta","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1530\/JME-11-0189","article-title":"The microRNA Cluster C19MC Is Deregulated in Parathyroid Tumours","volume":"49","author":"Vaira","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0480","article-title":"Profiling Analysis of Long Non-Coding RNA and mRNA in Parathyroid Carcinoma","volume":"26","author":"Zhang","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4154","article-title":"The Oncosuppressors MEN1 and CDC73 Are Involved in lncRNA Deregulation in Human Parathyroid Tumors","volume":"35","author":"Morotti","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2015.1108507","article-title":"MIR517C Inhibits Autophagy and the Epithelial-to-Mesenchymal (-Like) Transition Phenotype in Human Glioblastoma Through KPNA2-Dependent Disruption of TP53 Nuclear Translocation","volume":"11","author":"Lu","year":"2015","journal-title":"Autophagy"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.10.027","article-title":"Down-Regulation of miR-517a and miR-517c Promotes Proliferation of Hepatocellular Carcinoma Cells via Targeting Pyk2","volume":"329","author":"Liu","year":"2013","journal-title":"Cancer Lett"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1261\/rna.029561.111","article-title":"MicroRNAs 296 and 298 Are Imprinted and Part of the GNAS\/Gnas Cluster and miR-296 Targets IKBKE and Tmed9","volume":"18","author":"Robson","year":"2012","journal-title":"RNA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjy041","article-title":"miR-221\/222 Activate the Wnt\/beta-Catenin Signaling to Promote Triple-Negative Breast Cancer","volume":"10","author":"Liu","year":"2018","journal-title":"J Mol Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel2011.08.018","article-title":"Molecular Mechanisms of Long Noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.229","article-title":"Long Non-Coding RNAs as Regulators of the Endocrine System","volume":"11","author":"Knoll","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-016-0530-6","article-title":"Long Noncoding RNAs in Cancer: Mechanisms of Action and Technological Advancements","volume":"15","author":"Bartonicek","year":"2016","journal-title":"Mol Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long Noncoding RNAs in Cancer Pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0188","article-title":"Long Noncoding RNAs: Emerging Players in Thyroid Cancer Pathogenesis","volume":"25","author":"Murugan","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2018.05.003","article-title":"BC200 (BCYRN1) - The Shortest, Long, Non-Coding RNA Associated With Cancer","volume":"3","author":"Samson","year":"2018","journal-title":"Noncoding RNA Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0707","article-title":"Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation Through Epigenetically Regulating LATS2 Expression","volume":"15","author":"Wan","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2019.1622962","article-title":"Circular RNA Profile of Parathyroid Neoplasms: Analysis of Co-Expression Networks of Circular RNAs and mRNAs","volume":"16","author":"Hu","year":"2019","journal-title":"RNA Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-20-0450","article-title":"Gene Expression Profile in Metastatic and Non-Metastatic Parathyroid Carcinoma","volume":"28","author":"Condello","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.21873\/cgp.20297","article-title":"Parathyroid Carcinoma and Adenoma Co-Existing in One Patient: Case Report and Comparative Proteomic Analysis","volume":"18","author":"Ciregia","year":"2021","journal-title":"Cancer Genomics Proteomics"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.11.051","article-title":"Ubiquitin C-Terminal Hydrolase-L1 Plays a Key Role in Angiogenesis by Regulating Hydrogen Peroxide Generated by NADPH Oxidase 4","volume":"495","author":"Song","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"16287","DOI":"10.18632\/oncotarget.3843","article-title":"Ubiquitin C-Terminal Hydrolase-L1 Increases Cancer Cell Invasion by Modulating Hydrogen Peroxide Generated via NADPH Oxidase 4","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"B65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/jcb.26232","article-title":"UCH-L1 Promotes Invasion of Breast Cancer Cells Through Activating Akt Signaling Pathway","volume":"119","author":"Luo","year":"2018","journal-title":"J\u00a0Cell Biochem"},{"key":"B66","article-title":"UCH-L1 Involved in Regulating the Degradation of EGFR and Promoting Malignant Properties in Drug-Resistant Breast Cancer","volume":"8","author":"Jin","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22376","article-title":"Overexpression of Ubiquitin Carboxyl Terminal Hydrolase-L1 Enhances Multidrug Resistance and Invasion\/Metastasis in Breast Cancer by Activating the MAPK\/Erk Signaling Pathway","volume":"55","author":"Wang","year":"2016","journal-title":"Mol Carcinog"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.09.028","article-title":"Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer","volume":"64","author":"Wang","year":"2016","journal-title":"Mol Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133525","article-title":"CLIC1 Recruits PIP5K1A\/C to Induce Cell-Matrix Adhesions for Tumor Metastasis","volume":"131","author":"Peng","year":"2021","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02445-0","article-title":"CLIC1 Knockout Inhibits Invasion and Migration of Gastric Cancer by Upregulating AMOT-P130 Expression","volume":"223","author":"Qiu","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/antiox6040086","article-title":"Insights Into the Dichotomous Regulation of SOD2 in Cancer","volume":"6","author":"Kim","year":"2017","journal-title":"Antioxidants (Basel)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.834362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T07:58:22Z","timestamp":1645689502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.834362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":71,"alternative-id":["10.3389\/fendo.2022.834362"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.834362","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"834362"}}